China Deal Monitor: Biopharma firm Cytovant nets $23.5m and more updates

China Deal Monitor: Biopharma firm Cytovant nets $23.5m and more updates

03 April, 2020

BNH Investment Cytovant Suzhou Ribo Life Science

Printed by Unregistered user on Sun, 13 Jul 2025 06:05:39 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China Deal Monitor: Intel Capital leads $14m Series B round in KFBIO and more updates

China Deal Monitor: YuanBio Venture Capital invests in PushKang and more updates

Read more from Greater China

Editor’s Take: The Week That Was—July 7-12

Policy & Regulations

Shanghai to consider policy responses to stablecoins, cryptocurrencies